Schedule 13D ownership disclosure

RENEO PHARMACEUTICALS INC

Security class unavailable · CUSIP: 75974E103

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
14.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-22-019678
Form type
SC 13D/A
Filer
Novo Holdings A/S
CIK
CIK 1388325
Filed
Jan 27, 2022
Reporting period
—
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub